Repare Therapeutics Inc. Quarterly Operating Income (Loss) in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Repare Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
  • Repare Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$36.4M, a 5.33% increase year-over-year.
  • Repare Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$93.7M, a 10.7% increase year-over-year.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$116M, a 487% decline from 2022.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$19.8M, a 81.8% increase from 2021.
  • Repare Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$109M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$93.7M -$36.4M +$2.05M +5.33% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$95.8M -$37.3M -$25.1M -204% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$70.7M $10.8M +$45.5M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$116M -$30.9M -$11.2M -57.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$105M -$38.4M -$112M -152% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $6.83M -$12.3M +$26.5M +68.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$19.6M -$34.7M +$148K +0.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$19.8M -$19.6M +$9.1M +31.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$28.9M $73.4M +$105M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$134M -$38.7M -$12.1M -45.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$122M -$34.8M -$13.2M -61.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$109M -$28.7M -$11.7M -68.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$97M -$31.7M -$17.6M -125% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$79.4M -$26.7M -$14.3M -116% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$65.1M -$21.6M -$10.8M -99.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$54.3M -$17.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$14.1M -$7.22M -105% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$12.3M -$6.44M -109% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$10.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 -$6.87M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.89M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.